Intellectual Property India Publishes Patent Application for 'A Novel In-Situ Nanoemulgel To Reduce Adverse Drug Reaction Induced By Antiglaucoma Drugs' Filed by Gd Goenka University

MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511124318 A) filed by Gd Goenka University, Sohna, Haryana, on Dec. 9, 2025, for 'a novel in-situ nanoemulgel to reduce adverse drug reaction induced by antiglaucoma drugs.'

Inventor(s) include Monika Singh; Dr. Vikas Jhawat; and Ms. Monika Gulia.

The application for the patent was published on Jan. 23, under issue no. 04/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to a novel in-situ nanoemulgel to reduce adverse drug reaction induced by antiglaucoma drugs. The present invention includes a bimatoprost, an oil phase, a hyaluronic acid, an emulsifier I, an emulsifier II, a water and a ...